Adverse Drug Reactions Increase the Risk of Drug-Resistant Tuberculosis

Liena Sofiana; Lutfia Alfina

doi:10.33086/mtphj.v10i2.6101

pdf

Published Sep 14, 2026

DOI https://doi.org/10.33086/mtphj.v10i2.6101

Liena Sofiana

Universitas Ahmad Dahlan Indonesia

Lutfia Alfina

Universitas Ahmad Dahlan Indonesia

Abstract

Drug-resistant tuberculosis is diagnosed in Indonesia every year, and 48% of cases begin second-line TBC treatment. Cases of resistance result in high rates of TBC medication failure, increasing morbidity and death. The purpose of this study is to identify the variables that contribute to the occurrence of drug-resistant tuberculosis at the Respira Lung Hospital in Yogyakarta. The study is a quantitative analysis using a retrospective cohort design. This research included 250 TBC patients from the Respira Lung Hospital Yogyakarta between 2021 and 2022. The sampling method employed was simple random sampling. Data was collected utilizing medical records. The chi-squared and logistic regression tests were used to analyze the data. The study found that age (p=0.033; RR=3.220), drug side effect status (p=0.001; RR=6.457), gender (p=0.098; RR=2.4), medication adherence (p=0.509; RR=1.457), previous medication history (p=1.00; RR=0.940), and comorbid diseases (p=0.520; RR=1.416) were all associated with the incidence of drug-resistant tuberculosis. The most important factor influencing the occurrence of treatment-resistant tuberculosis is the variability of treatment side effects.

Keywords: Risk factors, drug-resistant tuberculosis; drug side effects

Downloads

Download data is not yet available.

How to Cite

Liena Sofiana, & Alfina, L. (2026). Adverse Drug Reactions Increase the Risk of Drug-Resistant Tuberculosis. Medical Technology and Public Health Journal , 10(2), 161–171. https://doi.org/10.33086/mtphj.v10i2.6101

Download Citation

Issue

Vol. 10 No. 2 (2026): Medical Technology and Public Health Journal September 2026

Section

Articles

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Risk factors, drug-resistant tuberculosis, drug side effects

References

Afilla Christy, B., Susanti, R., & Nurmainah, N. (2022). Hubungan Tingkat Kepatuhan Minum Obat Pasien Tuberkulosis Terhadap Efek Samping Obat Anti Tuberkulosis (OAT). Journal Syifa Sciences and Clinical Research, 4(2), 484–493. https://doi.org/10.37311/jsscr.v4i2.14830

Aminah, N. S., & Djuwita, R. (2021). Trend dan Faktor yang Berhubungan dengan Keberhasilan Pengobatan Pasien TB MDR Paduan Jangka Pendek di Indonesia 2017-2019. Pro Health Jurnal Ilmiah Kesehatan, 3(1).

Anisah, A., Sumekar, D. W., & Budiarti, E. (2021). Hubungan Demografi dan Komorbid dengan Kejadian Tuberkulosis Resisten Obat (TB RO). Jurnal Ilmiah Kesehatan Sandi Husada, 10(2), 568–574. https://doi.org/10.35816/jiskh.v10i2.655

Annisa, N., & Hastono, S. P. (2019). Pengaruh Kategori Pengobatan Terhadap Keberhasilan Pengobatan Pasien Tuberkulosis. Jurnal Kesehatan Manarang, 5(2), 64–71.

Aristiana, C. D., & Wartono, M. (2018). Faktor-faktor yang mempengaruhi kejadian Multi Drug Resistance Tuberkulosis (MDR-TB). Jurnal Biomedika Dan Kesehatan, 1(1), 65–74. https://doi.org/10.18051/jbiomedkes.2018.v1.65-74

Baluku, J. B., Mukasa, D., Bongomin, F., Stadelmann, A., Nuwagira, E., Haller, S., Ntabadde, K., & Turyahabwe, S. (2021). Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study. BMC Infectious Diseases, 21(1), 1–11. https://doi.org/10.1186/s12879-021-06801-5

Bawonte, T. G., Mambo, C. D., & Masengi, A. S. R. (2021). Faktor-Faktor Yang Mempengaruhi Tuberculosis Multidrug Resistance (TB MDR). Jurnal E-Biomedik, 9(1), 117–125.

Buryanti, S., & Fibriana, A. I. (2021). Faktor-Faktor Yang Mempengaruhi Kejadian TB MDR Di Kota Semarang. Journal Health & Science: Gorontalo Journal Health and Science Community, 5(1), 146–154. https://doi.org/10.35971/gojhes.v5i1.9699

Christy, B. A., Susanti, R., & Nurmainah. (2022). Hubungan Tingkat Kepatuhan Minum Obat Pasien Tuberkulosis Terhadap Efek Samping Obat Anti Tuberkulosis ( OAT ). Journal Syifa Sciences and Clinical Research, 4(2), 484–493.

Damayanti, L., Widada, W., & Adi, S. (2022). Status Pengobatan Berhubungan Dengan Kejadian Tuberkulosis Resistan Obat Pada Usia Produktif. Profesional Health Journal, 3(2), 138–148.

Gumanti, S. T. A., Pradana, D. L. C., & Rifkia, V. (2020). Monitoring efek samping obat antituberkulosis fase intensif dan lanjutan pasien dewasa tuberkulosis di RSUD Kota Bandung. Jurnal Farmasi Indonesia, 12(1), 86–93. https://doi.org/10.35617/jfionline.v12i1.52

Kemenkes RI. (2020). Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat Di Indonesia.

Kemenkes RI. (2021). Pusat Data dan Informasi Kementrian Kesehatan RI.

Kurniasih, E., & Nurfajriani, V. J. (2021). Gambaran Tingkat Kecemasan Pasien Tb Paru Telaah Literatur. Ilmu Ilmu Keperawatan, 21, 78–91.

Lestari, N. P. W. A., Dedy, M. A. E., Artawan, I. M., & Buntoro, I. F. (2022a). Perbedaan Usia Dan Jenis Kelamin Terhadap Ketuntasan Pengobatan Tb Paru Di Puskesmas Di Kota Kupang. Cendana Medical Journal (CMJ), 10(1), 24–31.

Lestari, N. P. W. A., Dedy, M. A. E., Artawan, I. M., & Buntoro, I. F. (2022b). Perbedaan Usia Dan Jenis Kelamin Terhadap Ketuntasan Pengobatan Tb Paru Di Puskesmas Di Kota Kupang. Cendana Medical Journal, 23(1), 24–31. https://doi.org/10.35508/cmj.v10i1.6802

Manggasa, D. D., & Suharto, D. N. (2022). Riwayat Pengobatan dan Komorbid Diabetes Mellitus Berhubungan Dengan Kejadian Tuberkulosis Resisten Obat. Poltekita: Jurnal Ilmu Kesehatan, 15(4), 403–408. https://doi.org/10.33860/jik.v15i4.659

Marini, M., Suryaningtyas, N. H., & Santoso, S. (2023). Faktor Risiko Terjadinya Kasus Tuberkulosis Berulang Di Kabupaten Muara Enim Provinsi Sumatera Selatan. Majalah Kesehatan, 10(2), 99–110. https://doi.org/10.21776/majalahkesehatan.2023.010.02.3

Oliviera, I., Kholis, F. N., & Ngestiningsih, D. (2016). Pola Kejadian Penyakit Komorbid Dan Efek Samping OAT pada Pasien Tuberkulosis di RSUP Dr. Kariadi. Jurnal Kedokteran Diponegoro, 5(4), 1081–1091. http://ejournal-s1.undip.ac.id/index.php/medico

Oliviera, I., Kholis, F. N., & Ngestiningsih, D. (2017). Pola Kejadian Penyakit Komorbid Dan Efek Samping. Jurnal Kedokteran Diponegoro, 5(4), 1081–1091.

Pangaribuan, L., Kristina, K., Perwitasari, D., Tejayanti, T., & Lolong, D. B. (2020). Faktor-Faktor yang mempengaruhi kejadian tuberkulosis pada umur 15 tahun ke atas di Indonesia. Buletin Penelitian Sistem Kesehatan, 23(1), 10–17.

Pasaribu, G. F., Handini, M. C., Manurung, J., & Manurung, K. (2022). Ketidakpatuhan minum obat pada pasien TB paru : Studi kualitatif. Jurnal Prima Medika Sains Vol.5 No.1, 5(1), 48–56. https://doi.org/10.34012/jpms.v5i1.3788

Rumimpunu, R., Maramis, F. R. R., & Kolibu, F. K. (2018). Hubungan Antara Dukungan Keluarga Dan Dorongan Petugas Kesehatan Dengan Kepatuhan Berobat Penderita Tuberkulosis Paru Di Puskesmas Likupang Kabupaten Minahasa Utara. KESMAS: Jurnal Kesehatan Masyarakat Universitas Sam Ratulangi, 7(4).

Sitopu, S. D., Silalahi, D., & Lase, Y. K. (2022). Hubungan Kepatuhan Minum Obat Dengan Kesembuhan Pasien Tuberkulosis Paru (TB Paru) Di Puskesmas Pulo Brayan Kota Medan Tahun 2022. Jurnal Darma Agung Husada, 9(2), 48–55. https://doi.org/http://dx.doi.org/10.46930/darmaagunghusada.v9i2.2400

Tetrapoik, J. C., Nugroho, K. P. A., & De Fretes, F. (2020). Upaya Keluarga dalam Perawatan Klien TB Paru dengan Komorbid Diabetes Melitus Di Kota Salatiga. Jurnal Sains Dan Kesehatan, 2(4), 331–339. https://doi.org/10.25026/jsk.v2i4.159

Wahyuni, T. (2020). Faktor-faktor yang berhubungan dengan kejadian multidrug resistant tuberkulosis (mdr-tb). 96.

Wahyuni, T., & Cahyati, W. H. (2020). Multidrug Resistant Tuberculosis (MDR). Higeia: Journal of Public Health Research and Development, 4(Special 3), 636–648. https://doi.org/10.1016/j.cca.2024.119701

World Health Organization. (2021). Tuberkulosis.

Adverse Drug Reactions Increase the Risk of Drug-Resistant Tuberculosis